Tesamorelin vs Sermorelin Cost Per Mg Comparison

A tesamorelin vs sermorelin cost per mg comparison only means something once both listings are converted to the same unit. Sticker prices sit at different vial sizes, different mg totals, and sometimes different purity claims, so a $10 gap between two listings can flip direction entirely once the math is done per milligram instead of per vial.

What “Cost Per Mg” Actually Measures

A vial’s listed price covers whatever total mg of peptide is in that vial, not a standardized unit. A 5 mg vial and a 10 mg vial from the same source rarely cost double one another; larger vials usually carry a lower per-mg rate because packaging, labeling, and handling costs don’t scale linearly with peptide content. Cost per mg strips that packaging effect out and gives a number that can be placed next to a listing of a different compound, different vial size, or different source.

The formula is simple: take the listed price and divide by the mg total stated on the vial or COA. That number is the only one worth comparing across a tesamorelin and a sermorelin listing, since the two compounds are rarely sold in matching vial sizes.

Vial Sizes and Why They Skew Sticker Price

Tesamorelin is most commonly listed in vials in the 5-10 mg range. Sermorelin listings vary more widely, with some sources offering smaller vials aimed at lower total mg per unit. Because sermorelin is a shorter peptide chain than tesamorelin, sourcing and synthesis costs differ, and that difference shows up in how vials are sized and priced well before any per-mg comparison is made.

This is why comparing two sticker prices side by side, without dividing by mg, produces a misleading picture. A lower sticker price on a smaller vial can still represent a higher cost per mg than a higher sticker price on a larger one.

A Worked Example: Two Listings, Same Math

Consider a hypothetical tesamorelin listing priced at $120 for a 10 mg vial, and a hypothetical sermorelin listing priced at $45 for a 5 mg vial.

• Tesamorelin: $120 ÷ 10 mg = $12.00 per mg
• Sermorelin: $45 ÷ 5 mg = $9.00 per mg

Recomputing to confirm: 120 divided by 10 is 12, and 45 divided by 5 is 9. In this illustrative pair, the sermorelin listing carries a lower cost per mg, even though its sticker price is also lower in absolute terms. That overlap between sticker price and per-mg price is coincidental here and won’t hold across every pair of listings, which is exactly why the per-mg conversion matters more than the headline number.

Reconstitution math sits downstream of this same per-mg figure. If that 10 mg tesamorelin vial is reconstituted with 2 mL of bacteriostatic water, the resulting concentration is 10 mg ÷ 2 mL = 5 mg/mL. On a U-100 insulin syringe, where 1 mL equals 100 units, each unit then represents 5 mg ÷ 100 = 0.05 mg, or 50 mcg. That figure describes concentration only — it says nothing about a dose, since dosing decisions sit outside what a pricing comparison can address. Readers working through reconstitution ratios by hand can cross-check the arithmetic against a tool like peptcalc.com rather than relying on a single manual calculation.

Table: Comparing Cost Per Mg Across Listing Types

Listing pattern	Typical vial size	Effect on cost per mg
Small vial, premium framing	2-5 mg	Often the highest per-mg rate
Mid-size vial, standard listing	5-10 mg	Middle of the range, most common comparison point
Bulk or multi-vial bundle	10 mg and up, sold in sets	Lowest per-mg rate, but requires larger upfront spend
Listing with COA and purity data included	Varies	Per-mg rate may run higher, reflecting documentation and testing overhead

This table describes patterns across listing structures generally, not fixed prices for either compound, since actual figures shift by source and by date.

Why Sermorelin Listings Often Show a Lower Per-Mg Figure

Sermorelin is a shorter amino acid sequence than tesamorelin, which typically translates to lower synthesis cost per mg at the manufacturing stage. That cost difference can carry through to the listed price, which is one reason sermorelin cost per mg figures often land below tesamorelin ones across comparable sources. This is a structural difference in the compounds themselves, not a reflection of quality or documentation standards at any given source.

It’s also why a tesamorelin vs sermorelin cost per mg comparison should be read as a comparison of two different molecules with different production economics, not as two competing prices for the same product. A buyer evaluating both should weigh the per-mg figure alongside what each listing documents about purity and testing, not price alone.

Purity, COA Documentation, and What the Price Doesn’t Show

A lower cost per mg does not by itself indicate a better or worse listing. Two of the most useful things a listing can disclose alongside price are whether a current certificate of analysis is available and what testing method produced it — HPLC purity testing being the standard most listings reference when they cite a specific percentage. A listing that publishes a COA and a listing that only states a purity percentage without supporting documentation are not equivalent, even if their per-mg prices are identical.

Buyers who want to see how a single source documents vial specifications alongside COA data for a specific compound can review a tesamorelin listing directly, then apply the same per-mg math described above to that listing’s price and vial size.

Reading Listings Across Sources

When comparing tesamorelin and sermorelin listings across multiple sources, the most reliable process is: convert every price to cost per mg first, note the vial size and any reconstitution instructions separately, and only then compare documentation quality between listings sitting at similar per-mg rates. Skipping the conversion step and comparing sticker prices directly is the most common source of confusion in this kind of comparison.

Readers tracking pricing across the broader GHRH-analog category may also find it useful to cross-reference listings gathered across peer tesamorelin listing catalogs, since a peptide-focused tracker can surface entries that don’t appear in any single source’s own table.

Summary

Comparing tesamorelin and sermorelin on cost alone requires converting every listing to price per mg before any conclusion is drawn, since vial size and compound-specific production costs distort sticker price on their own. Once that conversion is done, the more informative comparison is between what each listing documents — COA availability, testing method, and vial specifications — rather than the raw number alone.